Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon Dose-Response in Post-Bariatric Hypoglycemia
NCT06986603Phase 4Active, not recruiting
- Sponsor
- Joslin Diabetes Center
- Start
- Nov 2024
- Primary completion
- Jun 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of glucagon in post-bariatric hypoglycemia (PBH), sponsored by Joslin Diabetes Center. Started Nov 2024; status: active, not recruiting.
02
Drugs
glucagon
03
Conditions
post-bariatric hypoglycemia (PBH)
Beyond the preview
Go deeper on NCT06986603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06986603.